U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: July 26 - August 1, 2020
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: July 26 - August 1, 2020

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 07/28/2020
Location: Virtual
Subject: National Food Policy Conference
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, media, industry, academia and other registered guests

Event Date: 07/29/2020
Location: Raleigh, NC
Subject: Operation Warp Speed Clinic Tour and Press Briefing
FDA Participant/Group: N/A
Non FDA Participant/Group: Media, government, and industry

Event Date: 07/30/2020
Location: Virtual
Subject: JAMA Live: COVID-19 Vaccine Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Howard Bauchner (JAMA Network);

Event Date: 07/30/2020
Location: Teleconference
Subject: American College of Rheumatology Leadership: COVID-19 Update
FDA Participant/Group: RACHEL GLASER; VALERIE JENSEN; ELENI ANAGNOSTIADIS; NIKOLAY NIKOLOV; JOHN WAGNER; DAYLE CRISTINZIO;
Non FDA Participant/Group: Several representatives of the medical industry and members of the American College of Rheumatology leadership

Event Date: 07/31/2020
Location: Teleconference
Subject: Surgical Face Masks
FDA Participant/Group: ANAND SHAH; COLIN ROM;
Non FDA Participant/Group: Jason Duncan (Outdoor Research);

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 07/28/2020
Location: Virtual
Subject: National Academy of Medicine Leadership Consortium
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and other stakeholders

Event Date: 07/29/2020
Location: Virtual
Subject: Jumpstart Access Clinical Data for COVID-19 Research Workshop
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, patients, federal government, and other stakeholders

Event Date: 07/29/2020
Location: Virtual
Subject: Duke Clinical Research Institute (DCRI) Think Tank - Navigating Clinical Trials in the COVID-19 Era: An Accelerated Shift Towards Direct-to-Patient, Virtual and Hybrid Trials
FDA Participant/Group: N/A
Non FDA Participant/Group: Patients, providers, academia, industry, and other stakeholders

Event Date: 07/30/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, health care providers, industry, academia, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

Event Date: 07/30/2020
Location: Webinar
Subject: Federalist Society Teleforum; COVID-19 and FDA: Medical, Legal, and Regulatory Perspectives
FDA Participant/Group: STACY AMIN; ANAND SHAH;
Non FDA Participant/Group: Open to the public

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 07/29/2020
Location: Virtual
Subject: Produce Safety Issues
FDA Participant/Group: CAITLIN BOON; LARRY MORRIS; JEFFREY FARRAR;
Non FDA Participant/Group: Barb Glenn, Bob Ehart, Joe Reardon, Max Moncaster (National Association of State Departments of Agriculture);

Event Date: 07/30/2020
Location: Virtual
Subject: Leafy Greens Action Plan Webinar
FDA Participant/Group: Several FDA senior officials and staff
Non FDA Participant/Group: Several leaders from across the produce industry, academia, and trade associations

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: John Wagner, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 07/28/2020
Location: Virtual
Subject: The Art of Gene Therapy Digital Summit; Regulatory Horizons: 2020 Vision on FDA Guidelines
FDA Participant/Group: N/A
Non FDA Participant/Group: Gene therapy industry stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 07/30/2020
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: American Veterinary Medical Association House of Delegates

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event

 

Back to Top